123 / 490
121
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
MONDAY 2 MAY 2016
Symposium with Proffered Papers
ADAPTIVE RADIOTHERAPY FOR COPINGWITH ANATOMICAL
VARIATIONS: HOPE OR HYPE?
08:45 - 10:00 | ROOM 2
A huge step in radiation therapy is the introduction of Adaptive Radiotherapy (ART). With ART the
treatment can be individualised, according to changes in the anatomy of the patient. To date the clinical
implications are not yet known; several studies are developed to get more information concerning
these clinical implications. In this symposium, we will focus on different ART strategies, selection of the
patients, as well as the practical challenges and costs of ART.
Chair: M. Mast (The Netherlands)
Co-chair: G. Guidi (Italy)
08:45 > Overview of clinical practice of ART for pelvic tumours
Speaker: S. Thörnqvist (Norway), L.B. Hysing, L. Tuomikoski,
A. Vestergaard, K. Tanderup, L.P. Muren, B.J.M. Heijmen
SP-0392
09:05 > The challenges of ART from a physician's perspective
Speaker: S. Nuyts (Belgium)
SP-0393
09:25 > The practical “costs” of adaptive radiotherapy
Speaker: C. Rowbottom (UK)
SP-0394
09:45 > Patient selection in head and neck adaptive radiotherapy
C. Brouwer (The Netherlands), R. Steenbakkers, A. Van der Schaaf,
C. Sopacua, L. Van Dijk, R. Kierkels, H. Bijl, J. Burgerhof, J. Langendijk,
N. Sijtsema
OC-0395
Symposium with Proffered Papers
TIME IS NOT ON OUR SIDE: CARDIOVASCULAR TOXICITY AFTER
RADIOTHERAPY
08:45 - 10:00 | ROOM 4
Radiotherapy is often used in patients with expected prolonged disease-free-survival. Long term follow
up of cancer survivors, indicated that the therapeutic effect of radiotherapy is compromised by cardio-
vascular disease (CAD) aggravated by radiation exposure of the heart and coronary arteries. Recent
publications have shown a dose-effect relationship with no apparent threshold. In this multidisciplinary
symposium we will discuss the clinical aspects of CAD along with quantitative analyses beyond the
QUANTEC and whether the use of innovative techniques compared to conventional radiation will
change the magnitude of radiation induced CAD. Impotently, we will show that in 2016 we still have
open questions.
Chair: O. Kaidar-Person (Israel)
Co-chair: C. Fiandra (Italy)
08:45 > The risk of cardiovascular disease after breast cancer treatment:
the clinician's point of view
Speaker: C. Taylor (UK)
SP-0396